Advertisement
Screener

Pharming Group N.V. (PHAR) Form 6-K: Report of foreign private issuer, 2025

Add as a preferred source on Google

Pharming Group N.V. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2025-11-06: Form 6-K; Period of report 2025-11-06; Description 6-K; Document a2025q3pressrelease.htm.
  • 2025-10-22: Form 6-K; Period of report 2025-10-20; Description 6-K; Document pharminggroupannouncespres.htm.
  • 2025-10-06: Form 6-K; Period of report 2025-10-06; Description 6-K; Document pharminggroupprovidesupdat.htm.
  • 2025-10-01: Form 6-K; Period of report 2025-10-01; Description 6-K; Document pharminggroupannouncesusfd.htm.
FiledFormPeriod of reportDescriptionDocument
2025-11-066-K2025-11-066-Ka2025q3pressrelease.htm
2025-10-226-K2025-10-206-Kpharminggroupannouncespres.htm
2025-10-066-K2025-10-066-Kpharminggroupprovidesupdat.htm
2025-10-016-K2025-10-016-Kpharminggroupannouncesusfd.htm
2025-09-106-K2025-09-106-Kpharminggrouppromotedtothe.htm
2025-09-026-K2025-09-026-Kpharminggroupappointskenne.htm
2025-07-316-K2025-07-316-Ka2025hy1pressrelease.htm
2025-06-246-K2025-06-246-Kpharminggrouptohostwebcast.htm
2025-06-116-K2025-06-116-Kpharminggroupreportsonresu.htm
2025-05-086-K2025-05-086-Ka2025q1pressrelease.htm
2025-04-306-K2025-04-306-Kpharminggroupannouncesthe2.htm
2025-04-256-K2025-04-256-Kpharminggroupannouncesupco.htm
2025-04-236-K2025-04-236-Kpharmingreceivespositivere.htm
2025-04-036-K2025-04-036-Kpharminggroupannouncesthef.htm
2025-03-206-K2025-03-206-Kpharminggroupannouncesfirs.htm
2025-03-136-K2025-03-136-Ka2024q4pressrelease.htm
2025-03-046-K2025-03-046-Kpharminggroupreportsonresu.htm
2025-02-206-K2025-02-206-Kpharmingtechnologiesbvincr.htm
2025-02-076-K2025-02-076-Kpharmingtechnologiesbvdecl.htm
2025-01-216-K2025-01-216-Kpharminggrouptoconveneextr.htm
2025-01-216-K2025-01-216-Kpharmingtonominatebiopharm.htm
Advertisement